Skip to main content

Table 4 Univariate and multivariate analysis of SDC1 and Clinical characteristic with distant recurrence

From: Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway

Clinical characteristic

Univariable analysis

Multivariable analysis

HR

95%CI

P value

HR

95%CI

P value

Menopause

1.12

0.66–1.90

0.67

   

Tumor grade

0.72

0.42–1.25

0.25

   

T stage

1.95

1.25–3.07

0.004

1.36

0.78–2.37

0.27

N stage

1.86

1.45–2.37

< 0.001

1.70

1.26–2.29

< 0.001

SDC1 in tumor cell

2.08

1.10–3.91

0.02

1.94

0.92–4.07

0.08

SDC1 in CAF

0.33

0.14–0.79

0.012

0.35

0.13–0.91

0.03